Administration Route- and Immune Cell Activation-Dependent Tumor Eradication by IL12 electrotransfer

This publication has 33 references indexed in Scilit:

• Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation
  Experimental & Molecular Medicine, 2002
• Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA array
  Gene Therapy, 2002
• Interleukin 12 Gene Therapy of Cancer by Peritumoral Injection of Transduced Autologous Fibroblasts: Outcome of a Phase I Study
  Human Gene Therapy, 2001
• Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site
  Gene Therapy, 2001
• Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model
  Clinical Endocrinology, 2000
• Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
  Gene Therapy, 1999
• Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
  Cancer Gene Therapy, 1999
• Rapid recruitment of macrophages in interleukin‐12‐mediated tumour regression
  Immunology, 1998
• Clinical Trials: IL-12 Deaths: Explanation and a Puzzle
  Science, 1995
• Role of IL12 as an anti-tumour agent: current status and future directions
  Research in Immunology, 1995